Related Experiment Video
Updated: Jun 5, 2026

10:48
Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression
Published on: May 15, 2014
The Vaccinia virus complement control protein modulates adaptive immune responses during infection
Natasha M Girgis1, Brian C Dehaven, Yuhong Xiao
1University of Pennsylvania School of Medicine, Division of Infectious Diseases, 502 Johnson Pavilion, Philadelphia, PA 19104-6073, USA.
Journal of Virology
|December 31, 2010
Summary
Vaccinia virus complement control protein (VCP) dampens anti-viral immune responses. Inhibiting VCP in vaccinia virus enhances T cell and antibody responses, reducing viral virulence.
Area of Science:
- Immunology
- Virology
- Infectious Disease
Background:
- Complement activation is crucial for innate and adaptive immunity against viruses.
- Pathogen-encoded complement inhibitors can impact immune responses, but their mechanisms are often unclear.
- Vaccinia virus complement control protein (VCP) is a known virulence factor, but its precise role in modulating adaptive immunity is undefined.
Purpose of the Study:
- To investigate how vaccinia virus complement control protein (VCP) influences anti-viral T cell and antibody responses.
- To determine the role of VCP in vaccinia virus pathogenesis by comparing wild-type and VCP-deficient viruses.
- To elucidate the mechanisms by which VCP contributes to viral virulence.
Main Methods:
- Comparison of wild-type vaccinia virus (vv-VCPwt) and VCP-deficient vaccinia virus (vv-VCPko) in an intradermal mouse infection model.
- Assessment of lesion size, immune cell infiltration (T cells), antibody production, and viral titers.
- Experimental depletion of CD8(+) and CD4(+) T cells to evaluate their role in VCP-mediated virulence.
Main Results:
- VCP-deficient vaccinia virus (vv-VCPko) produced smaller lesions in wild-type mice, but not in complement-deficient mice, indicating VCP's role in virulence.
- Attenuation of vv-VCPko correlated with increased T cell accumulation, enhanced neutralizing antibody responses, and lower viral loads.
- Depletion of both CD8(+) and CD4(+) T cells restored the virulence of vv-VCPko to wild-type levels, highlighting the importance of T cell-mediated immunity.
Conclusions:
- Vaccinia virus complement control protein (VCP) contributes to viral virulence by suppressing anti-viral T cell and antibody responses.
- Pathogen-encoded complement regulatory proteins can significantly modulate adaptive immunity during viral infections.
- Targeting VCP or complement regulation pathways could be a strategy to enhance anti-viral immunity.
Related Concept Videos
Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Vaccinations
Overview
Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Cell-mediated Immune Responses
Overview

